Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

crenigacestat MeSH Supplementary Concept Data 2025


MeSH Supplementary
crenigacestat
Unique ID
C000654634
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000654634
Entry Term(s)
4,4,4-Trifluoro-N-((2S)-1-(((7S)-5-(2-hydroxyethyl)-6-oxo-6,7-dihydro-5H-pyrido(3,2-a)(3)benzazepin-7-yl)amino)-1-oxo-2-propanyl)butanamide
Butanamide, N-((1S)-2-(((7S)-6,7-dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido(3,2-a)(3)benzazepin-7-yl)amino)-1-methyl-2-oxoethyl)-4,4,4-trifluoro-
LY3039478
Registry Numbers
923X28214S
Heading Mapped to
*Benzazepines
Frequency
13
Note
NOTCH1 inhibitor
Source
Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4121-4127
Date of Entry
2019/11/12
Revision Date
2019/11/12
crenigacestat Preferred
LY3039478 Narrower
4,4,4-Trifluoro-N-((2S)-1-(((7S)-5-(2-hydroxyethyl)-6-oxo-6,7-dihydro-5H-pyrido(3,2-a)(3)benzazepin-7-yl)amino)-1-oxo-2-propanyl)butanamide Broader
page delivered in 0.006s